Clinical Research Directory
Browse clinical research sites, groups, and studies.
The Choice of Treatment Methods and Efficacy of LABC
Sponsor: Peking Union Medical College Hospital
Summary
The goal of this clinical trial is to compare the therapeutic effects of chemotherapy followed by surgery and surgery followed by chemotherapy in patients with locally advanced breast cancer(LABC). Patients with LABC will be randomly divided into two groups, each receiving chemotherapy followed by surgery or surgery followed by chemotherapy. The main comparison was between the disease-free survival (DFS) of two groups of patients, with the secondary study endpoint being overall survival (OS); Five year survival; Local recurrence or distant metastasis rate.
Official title: Treatment Selection and Efficacy of Locally Advanced Breast cancer-a Prospective Randomized Controlled Study
Key Details
Gender
FEMALE
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2023-10-08
Completion Date
2026-08-01
Last Updated
2023-10-12
Healthy Volunteers
No
Conditions
Interventions
Modified radical mastectomy for breast cancer
Modified radical mastectomy for breast cancer
neoadjuvant therapy
neoadjuvant chemotherapy(Drugs:" Doxorubicin""Paclitaxel""Albumin paclitaxel""Cyclophosphamide"), endocrine therapy(Drugs:"Toremifen""Zoladex""Aromatase inhibitors"), targeted therapy(Drugs:"trastuzumab""Pertuzumab")
Systematic treatment
chemotherapyDrugs:" Doxorubicin""Paclitaxel""Albumin paclitaxel""Cyclophosphamide"), endocrine therapy(Drugs:"Toremifen""Zoladex""Aromatase inhibitors"), targeted therapy(Drugs:"trastuzumab""Pertuzumab"),radiotherapy("Yikeda Versa HD linear accelerator""Varian Trilogy linear accelerator")
Locations (1)
Ying Xu
Beijing, China